Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5208830
Max Phase: Preclinical
Molecular Formula: C64H86N16O11S2
Molecular Weight: 1319.63
Associated Items:
ID: ALA5208830
Max Phase: Preclinical
Molecular Formula: C64H86N16O11S2
Molecular Weight: 1319.63
Associated Items:
Canonical SMILES: CC[C@H](C)[C@@H]1NC(=O)[C@@H]2CCCN2C(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)N(C)C(=O)[C@H](Cc2ccccc2)NC(=O)[C@H](Cc2cnc[nH]2)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](NC(C)=O)CSCc2ccccc2CSC[C@@H](C(N)=O)NC1=O
Standard InChI: InChI=1S/C64H86N16O11S2/c1-6-36(2)53-60(88)76-49(55(65)83)33-92-31-40-18-10-11-19-41(40)32-93-34-50(72-38(4)82)57(85)78-54(37(3)81)61(89)73-46(28-43-30-68-35-71-43)56(84)74-47(26-39-16-8-7-9-17-39)62(90)79(5)51(22-14-24-69-64(66)67)58(86)75-48(27-42-29-70-45-21-13-12-20-44(42)45)63(91)80-25-15-23-52(80)59(87)77-53/h7-13,16-21,29-30,35-37,46-54,70,81H,6,14-15,22-28,31-34H2,1-5H3,(H2,65,83)(H,68,71)(H,72,82)(H,73,89)(H,74,84)(H,75,86)(H,76,88)(H,77,87)(H,78,85)(H4,66,67,69)/t36-,37+,46-,47-,48-,49-,50-,51-,52-,53-,54-/m0/s1
Standard InChI Key: CVFOOTMEXJIPIT-ZQZJLAJUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1319.63 | Molecular Weight (Monoisotopic): 1318.6103 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. White AM, Dellsén A, Larsson N, Kaas Q, Jansen F, Plowright AT, Knerr L, Durek T, Craik DJ.. (2022) Late-Stage Functionalization with Cysteine Staples Generates Potent and Selective Melanocortin Receptor-1 Agonists., 65 (19.0): [PMID:36167503] [10.1021/acs.jmedchem.2c00793] |
Source(1):